Processa Pharmaceuticals has made a push into the autoimmune space via the acquisition of Vidya Therapeutics and its potential rival to Novartis’ Rhapsido. The all-stock deal will secure Processa an ...

Millions of people who recover from the initial stages of COVID-19 continue to suffer from lingering nerve pain, fatigue, and ...

Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward ...

GTCR is running a continuation vehicle process for a wireless carrier it acquired five years ago, Secondaries Investor has learned. The Chicago-based private equity firm has launched a single-asset CV ...

Mast cells are tissue-resident immune sentinels best known for their central role in type I hypersensitivity and allergic inflammation. They express high-affinity receptors for immunoglobulin E (IgE), ...